Smith & Nephew has a number of executives responsible for the day-to-day management of the Group and committees which support the Chief Executive Officer. Executive Directors and Executive Officers (both persons discharging managerial responsibilities' (PDMR)), and the Chief Executives Officers direct reports are set out below.
Olivier Bohuon (55) Chief Executive Officer
Olivier was appointed Chief Executive Officer in April 2011. He is a member of the Nomination & Governance Committee. Olivier has had extensive international and leadership experience within a number of pharmaceutical and healthcare companies. Prior to joining Smith & Nephew, he was President of Abbott Pharmaceuticals, a division of Abbott Laboratories based in the US, where he was responsible for the entire business, including R&D, global manufacturing and global support functions.
He is Non-Executive Director of Virbac Group.
Julie Brown (51) Chief Financial Officer
Julie joined the Board on 4 February 2013 as Chief Financial Officer. She is a Chartered Accountant and Fellow of the Institute of Taxation with international experience and a deep understanding of the healthcare sector.
Julie trained with KPMG and then worked for AstraZeneca PLC, where she served as Vice President Group Finance, and more recently, as Interim Chief Financial Officer. Prior to that she held commercial roles as Regional Vice President Latin America, Marketing Company President AstraZeneca Portugal, and Vice President Corporate Strategy and R&D Chief Financial Officer. She has previously held Vice President Finance positions in all areas of the healthcare value chain including commercial, operations, R&D and business development.
Rodrigo Bianchi (54) President of IRAMEA
Rodrigo joined Smith & Nephew in July 2013 with responsibility for Greater China, India, Russia, Asia, Middle East and Africa, focusing on continuing our strong momentum in these regions. He is based in Dubai.
Rodrigo’s experience in the healthcare industry includes 26 years with Johnson & Johnson in progressively senior roles. Most recently, he was Regional Vice President for Medical Devices and Diagnostics division in the Mediterranean region and prior to that President of Mitek and Ethicon. He started his career at Procter & Gamble, Italy.
Jack Campo (59) Chief Legal Officer
Jack joined Smith & Nephew in June 2008 and heads up the Global Legal function. Initially based in London, he has been based in Andover, Massachusetts since late 2011.
Prior to joining Smith & Nephew, Jack held a number of senior legal roles within the General Electric Company, including seven years at GE Healthcare (GE Medical Systems) in the US and Asia. He began his career with Davis Polk & Wardwell.
Francisco Canal Vega (52) President, Latin America
Francisco joined Smith & Nephew in January 2012 and now leads the Latin American region, focusing on driving the substantial opportunities we see in this region.
Francisco has held senior management positions in global companies including Gambro AB and Baxter International. He has lived and worked in many countries including Switzerland, Germany, China, Japan, the US and Spain. Francisco was also formerly aboard member of EUCOMED.
Phil Cowdy (46) Head of Corporate Affairs and Strategic Planning
Phil is Smith & Nephew's Head of Corporate Affairs and Strategic Planning. He is responsible for all external Group communications, including Investor Relations and media, as well as Strategic Planning and Government Affairs. He joined in 2008.
Prior to joining Smith & Nephew, Phil was a senior Director at Deutsche Bank where he spent 13 years providing corporate finance and Equity Capital Markets advice to a wide range of UK corporates. He is a qualified chartered accountant.
Mike Frazzette (52) President, Advanced Surgical Devices
Mike joined Smith & Nephew in July 2006 as President of the Endoscopy Global Business Unit. Since July 2011, he has headed up the Advanced Surgical Devices division and is responsible for the Orthopaedic Reconstruction, Trauma and Endoscopy business. He is based in Andover, Massachusetts.
Mike has held a number of senior positions within the global medical devices industry. He was President and Chief Executive Officer of Micro Group, a US manufacturer of medical devices, and spent 15 years at Tyco Healthcare (Covidien) in various commercial roles eventually becoming President of the Patient Care and Health Systems divisions.
Gordon Howe (51) President, Global Operations
Gordon joined Smith & Nephew in 1998 and, since 2013, is responsible for manufacturing, supply chain and procurement, IT systems and Regulatory and Quality Affairs. Prior to that, he headed up the Global Planning and Business Development teams. He is based in Memphis, Tennessee.
Gordon has held a number of senior management positions within the Smith & Nephew Group, firstly in the Orthopaedics division and more recently at Group level. Prior to joining the Company, he held senior roles at United Technologies Corporation.
Helen Maye (54) Chief Human Resources Officer
Helen joined Smith & Nephew in July 2011 and leads the Global Human Resources and Internal Communications functions. Since 2013, she has also led the Sustainability, Health, Safety & Environment functions. She is based in London.
Helen has more than 35 years’ experience across a variety of international and global roles in medical devices and pharmaceuticals, including manufacturing, supply chain and human resources. Previously, she was Divisional Vice President of Human Resources at Abbott Laboratories.
Cyrille Petit (43) Chief Corporate Development Officer
Cyrille joined Smith & Nephew in May 2012 and leads the Corporate Development function. He is based in London.
Cyrille spent the previous 15 years of his career with General Electric Company, where he held progressively senior positions beginning with GE Capital, GE Healthcare and ultimately as the General Manager, Global Business Development of the Transportation Division. Cyrille’s career began in investment banking at BNP Paribas and then Goldman Sachs.
Arjun Rajaratnam (54) Chief Compliance Officer
Arjun joined the Group as Chief Compliance Officer in February 2009.
Arjun joined from GlaxoSmithKline, where he had worked for 14 years in a variety of compliance roles, most recently serving as Vice President & Compliance Officer, US Pharmaceuticals. Prior to this he worked at Sidley Austin. Arjun is a founding member and co-chair of the industry-wide Pharmaceutical Compliance Forum.
Susan Swabey (52) Company Secretary
Susan was appointed Company Secretary in May 2009.
Susan has 30 years' experience as a company secretary in a wide range of companies including Prudential plc, Amersham plc and RMC Group plc. Her work has covered Board support, corporate governance, corporate transactions, share registration, listing obligations, corporate social responsibility, pensions, insurance and employee and executive share plans. Susan is a member of the GC100 Group Executive Committee and the CBI Companies Committee and is a frequent speaker on corporate governance related matters.
She is a trustee of the charity, ShareGift.
Roger Teasdale (46) President, Advanced Wound Management
Roger joined Smith & Nephew in 1983 within the Wound Management business. He was appointed President of Advanced Wound Management in May 2009. He is based in Hull, UK.
Roger has held a number of key roles within the Smith & Nephew Group in both the UK and the US and has been responsible for leading the transformation of the Wound business in recent years.